TCT-733 Relation of Proton pump inhibitor and cytochrome P450 2C19 polymorphisms on pletelet reactivity in patients with acute coronary syndromes

Cytochrome P450 2C19 ◽

Evaluation of Proton Pump Inhibitor Use in Patients With Acute Coronary Syndromes Based on Risk Factors for Gastrointestinal Bleed

Critical Pathways in Cardiology ◽

10.1097/hpc.0b013e318159921e ◽

2007 ◽

Vol 6 (4) ◽

pp. 169-172 ◽

Cited By ~ 10

Author(s):

Geoffrey C. Schreiner ◽

Loren Laine ◽

Sabina A. Murphy ◽

Christopher P. Cannon

Keyword(s):

Risk Factors ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Gastrointestinal Bleed ◽

Incidence of Drug Interaction When Using Proton Pump Inhibitor and Warfarin According to Cytochrome P450 2C19 (CYP2C19) Genotype in Japanese

The Thoracic and Cardiovascular Surgeon ◽

10.1055/s-0034-1383814 ◽

2014 ◽

Vol 63 (01) ◽

pp. 045-050 ◽

Cited By ~ 4

Author(s):

Motomi Shiono ◽

Kenji Akiyama ◽

Akira Sezai ◽

Shinji Wakui ◽

Haruka Kimura ◽

...

Keyword(s):

Cytochrome P450 ◽

Drug Interaction ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Cyp2c19 Genotype ◽

029 Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele and proton pump inhibitor coadministration

Archives of Cardiovascular Diseases Supplements ◽

10.1016/s1878-6480(12)70425-1 ◽

2012 ◽

Vol 4 (1) ◽

pp. 10

Author(s):

Leila Abid ◽

Lobna Laroussi ◽

Nouha Abdelmoula ◽

Najla Kharrat ◽

Rania Abdelhédi ◽

...

Keyword(s):

Cytochrome P450 ◽

Cardiovascular Risk ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Loss Of Function ◽

Concomitant proton-pump inhibitor use, platelet activity, and clinical outcomes in patients with acute coronary syndromes treated with prasugrel versus clopidogrel and managed without revascularization: Insights from the Targeted Platelet Inhibition to Clarify the Optimal Strategy to Medically Manage Acute Coronary Syndromes trial

American Heart Journal ◽

10.1016/j.ahj.2015.05.017 ◽

2015 ◽

Vol 170 (4) ◽

pp. 683-694.e3 ◽

Cited By ~ 16

Author(s):

Jose Carlos Nicolau ◽

Deepak L. Bhatt ◽

Matthew T. Roe ◽

Yuliya Lokhnygina ◽

Benjamin Neely ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Clinical Outcomes ◽

Proton Pump ◽

Optimal Strategy ◽

Platelet Inhibition ◽

Platelet Activity ◽

Influence of Cytochrome P450 2C19 Polymorphisms on Exacerbating Effect of Proton Pump Inhibitor in Nonsteroidal Anti-Inflammatory Drugs-Induced Small Bowel Injury

Gastroenterology ◽

10.1016/s0016-5085(17)32793-2 ◽

2017 ◽

Vol 152 (5) ◽

pp. S807

Author(s):

Yoichiro Nuki ◽

Junji Umeno ◽

Ema Washio ◽

Yuji Maehata ◽

Atsushi Hirano ◽

...

Keyword(s):

Cytochrome P450 ◽

Small Bowel ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Bowel Injury ◽

Small Bowel Injury ◽

Cytochrome P450 2C19 ◽

Inflammatory Drugs ◽

Anti Inflammatory

Letter by Hnid and Chtioui Regarding Article, “Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction: Results From the French Registry of Acute ST-Elevation and Non–ST-Elevation Myocardial Infarction (FAST-MI) Registry”

Circulation ◽

10.1161/circulationaha.111.027912 ◽

2011 ◽

Vol 124 (11) ◽

Cited By ~ 1

Author(s):

Karim Hnid ◽

Mamoun Chtioui

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Cytochrome P450 ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

St Elevation Myocardial Infarction ◽

Clinical Events ◽

Cytochrome P450 2C19 ◽

St Elevation ◽

French Registry

Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease

Journal of Gastroenterology and Hepatology ◽

10.1111/j.1440-1746.2007.04942.x ◽

2007 ◽

Vol 22 (8) ◽

pp. 1286-1292 ◽

Cited By ~ 18

Author(s):

Yi-Chia Lee ◽

Jaw-Town Lin ◽

Hsiu-Po Wang ◽

Han-Mo Chiu ◽

Ming-Shiang Wu

Keyword(s):

Cytochrome P450 ◽

Genetic Polymorphism ◽

Gastroesophageal Reflux Disease ◽

Proton Pump Inhibitor ◽

Gastroesophageal Reflux ◽

Proton Pump ◽

Reflux Disease ◽

Chinese Patients ◽

THE ASSOCIATION BETWEEN CONCOMITANT PROTON-PUMP INHIBITOR USE AND CLINICAL OUTCOMES IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH PRASUGREL VERSUS CLOPIDOGREL AND MANAGED WITHOUT REVASCULARIZATION: INSIGHTS FROM THE TRILOGY ACS STUDY

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(13)60040-6 ◽

2013 ◽

Vol 61 (10) ◽

pp. E39 ◽

Cited By ~ 1

Author(s):

Jose C. Nicolau ◽

Deepak Bhatt ◽

Matthew Roe ◽

Benjamin Neely ◽

Ramon Corbalan ◽

...

Keyword(s):

Proton Pump Inhibitor ◽

Clinical Outcomes ◽

Proton Pump ◽

Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2009.12.071 ◽

2010 ◽

Vol 56 (2) ◽

pp. 134-143 ◽

Cited By ~ 273

Author(s):

Jean-Sébastien Hulot ◽

Jean-Philippe Collet ◽

Johanne Silvain ◽

Ana Pena ◽

Anne Bellemain-Appaix ◽

...

Keyword(s):

Cytochrome P450 ◽

Cardiovascular Risk ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Loss Of Function ◽

Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction

Circulation ◽

10.1161/circulationaha.110.965640 ◽

2011 ◽

Vol 123 (5) ◽

pp. 474-482 ◽

Cited By ~ 112

Author(s):

Tabassome Simon ◽

Philippe Gabriel Steg ◽

Martine Gilard ◽

Didier Blanchard ◽

Laurent Bonello ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Cytochrome P450 ◽

Proton Pump Inhibitor ◽

Proton Pump ◽

Clinical Events ◽